SC
CVS icon

Sawyer & Company’s CVS Health CVS Stock Holding History

Sawyer & Company’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-20,637
Closed -$926K – 176
2024
Q4 		$926K Sell
20,637
-320
-2% -$18K 0.34% 63
2024
Q3 		$1.32M Sell
20,957
-3
-0% -$175 0.49% 57
2024
Q2 		$1.24M Sell
20,960
-475
-2% -$29.7K 0.49% 57
2024
Q1 		$1.71M Sell
21,435
-207
-1% -$15.8K 0.68% 50
2023
Q4 		$1.71M Sell
21,642
-1,355
-6% -$96.4K 0.75% 48
2023
Q3 		$1.61M Sell
22,997
-13
-0.1% -$921 0.75% 49
2023
Q2 		$1.59M Hold
23,010
– – 0.73% 49
2023
Q1 		$1.75M Sell
23,010
-431
-2% -$36.1K 0.94% 44
2022
Q4 		$2.18M Sell
23,441
-395
-2% -$38.1K 1.08% 36
2022
Q3 		$2.27M Sell
23,836
-467
-2% -$46.2K 1.24% 30
2022
Q2 		$2.25M Sell
24,303
-1,215
-5% -$119K 1.14% 30
2022
Q1 		$2.58M Sell
25,518
-180
-0.7% -$18.9K 1.16% 30
2021
Q4 		$2.65M Sell
25,698
-318
-1% -$29.4K 1.14% 31
2021
Q3 		$2.21M Buy
26,016
+180
+0.7% +$15.1K 1.04% 40
2021
Q2 		$2.16M Sell
25,836
-40
-0.2% -$3.28K 1.01% 40
2021
Q1 		$1.95M Sell
25,876
-605
-2% -$44.1K 0.97% 37
2020
Q4 		$1.81M Sell
26,481
-125
-0.5% -$8.13K 0.92% 39
2020
Q3 		$1.55M Sell
26,606
-200
-0.7% -$12.4K 0.92% 39
2020
Q2 		$1.74M Sell
26,806
-10
-0% -$630 1.08% 33
2020
Q1 		$1.59M Sell
26,816
-97
-0.4% -$6.47K 1.27% 24
2019
Q4 		$2M Buy
26,913
+285
+1% +$20K 1.29% 24
2019
Q3 		$1.68M Buy
26,628
+27
+0.1% +$1.6K 1.2% 28
2019
Q2 		$1.45M Sell
26,601
-700
-3% -$37.7K 0.97% 34
2019
Q1 		$1.47M Sell
27,301
-364
-1% -$22.5K 0.96% 36
2018
Q4 		$1.81M Sell
27,665
-640
-2% -$47.8K 1.33% 25
2018
Q3 		$2.23M Buy
28,305
+50
+0.2% +$3.58K 1.36% 22
2018
Q2 		$1.82M Hold
28,255
– – 1.19% 25
2018
Q1 		$1.76M Hold
28,255
– – 1.19% 27
2017
Q4 		$2.05M Buy
+28,255
New +$2.05M 1.34% 20

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Sawyer & Company's CVS Position: Q1 2025 in Review

Sawyer & Company sold out of CVS Health (CVS) in Q1 2025, closing a stake of 20,637 shares — an estimated $926K sold.

Sawyer & Company first reported a position in CVS in Q4 2017 and held it in 29 quarters. The position peaked at $2.65M in Q4 2021. 1,756 funds tracked by Wall St. Rank hold CVS as of Q1 2025.

  • Sawyer & Company reported no remaining CVS Health position as of Q1 2025 after selling out during the quarter.
  • Sawyer & Company sold 20,637 CVS Health shares in Q1 2025, an estimated $926K.
  • Sawyer & Company first reported a position in CVS Health in Q4 2017 and held it in 29 quarters.
  • Sawyer & Company's CVS Health position peaked at $2.65M in Q4 2021.
  • 1,756 funds tracked by Wall St. Rank held CVS Health as of Q1 2025.

Based on Sawyer & Company's 13F filing for Q1 2025, filed 22 Apr 2025.